AstraZeneca Project Krystal Plant Expansion, Coppell, Texas
A construction project located in Coppell.
A Bit About AstraZeneca Project Krystal Plant Expansion, Coppell, Texas
Project Krystal is a pharmaceutical expansion built inside a plant that never stopped making medicine. DPR Construction spent two years threading new process systems through AstraZeneca’s existing 118,000-square-foot facility in Coppell, Texas, and ENR named the job the Best Project in manufacturing in its 2026 Texas & Southeast awards, with winners honored in Houston on Oct. 28, 2026.
AstraZeneca hasn’t said much publicly about the product. ENR describes the goal as strengthening domestic supply of a specialty medicine. CE&IC and Arcadis led design.
Project Scope
The team installed high-temperature, high-pressure processing systems, advanced process automation, clean-in-place systems, purified water generation and distribution, compressed air and vacuum, heat transfer systems and environmental monitoring, all within the existing building. Outside, a new tank farm added nine bulk storage tanks next to a dedicated raw material storage building.
Keeping the plant running drove every decision. Crews built a permanent separation wall through the facility and tied new lines into the live raw material distribution system so the new trains could draw from the existing plant as long as possible. When shutdowns came, several production trains went down at once, with dozens of concurrent work fronts covering power outages, equipment swaps, tie-ins, commissioning and operational readiness reviews.
Prefab carried a lot of the load. About 60% of the piping, utility racks and process assemblies were built off site, and major equipment sets and critical lifts were modeled in 4D and rehearsed as animations before crews touched them.
Why It Matters
Labor was the hidden constraint. ENR notes that much of North Texas’s specialty skilled workforce is tied up on semiconductor construction, so the team sourced and coordinated pharmaceutical trade partners from about a thousand miles away. That’s a problem every pharma owner planning U.S. capacity is going to run into as chip fabs, data centers and drug plants compete for the same pipefitters and instrumentation techs.
The safety record is the other headline. The project logged more than 1 million work hours with zero lost-time injuries, helped by multilevel fire watch programs that brought in off-duty local firefighters during hot work in sensitive manufacturing areas.
Drugmakers have pledged tens of billions for new U.S. plants, but plenty of that capacity will come from jobs like this one: brownfield expansions behind a separation wall, scheduled around production rather than a groundbreaking. Coppell’s team showed it can be done without losing output.
Project Team & Details
| Owner / Client | AstraZeneca |
|---|---|
| Architect | CE⁣ Arcadis |
| General Contractor | DPR Construction |
| Status | Completed |
| Funding Source | Private |
Where to find this project
Sorry, no records were found. Please adjust your search criteria and try again.
Sorry, unable to load the Maps API.
More images from AstraZeneca Project Krystal Plant Expansion, Coppell, Texas
Project Team & Details
| Owner / Client | AstraZeneca |
|---|---|
| Architect | CE⁣ Arcadis |
| General Contractor | DPR Construction |
| Status | Completed |
| Funding Source | Private |


